Balanced news tone
News Sentiment
KOD sentiment intelligence
Kodiak Sciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+7.2% over one week, +21.3% over four weeks, trend active, and materially above fair value.
Dow, S&P 500, Nasdaq Futures Rise After Trump’s 10-Day Iran Pause: Why META, DJT, U, KOD, MDGL Are Trending After-Hours
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Dow, S&P 500, Nasdaq Futures Rise After Trump’s 10-Day Iran Pause: Why META, DJT, U, KOD, MDGL Are Trending After-Hours
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 03:41
- Source
- Stocktwits
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Price to earnings forward of Kodiak Sciences, Inc. – LS:A2N6P0
This article provides access to the "Price to earnings forward" data for Kodiak Sciences, Inc. (stock symbol A2N6P0) on the TradingView platform. It highlights that the market was closed and no trades were made at the time of viewing, indicating a data point rather than a market
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jul 2026 15:39
- Source
- TradingView
Kodiak Sciences Inc (KOD) Stock Price | Live Quotes & Charts | NASDAQ
This page provides live stock quotes and charts for Kodiak Sciences Inc (KOD) on NASDAQ, showing a current price of $40.63 with a slight daily decrease. It also includes information on analyst ratings (though none are available), and highlights that earnings information is not cu
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 09 Jul 2026 21:11
- Source
- timothysykes.com
KODIAK SCIENCES INC (KOD) Stock Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 22:26
- Source
- ChartMill
Is Kodiak Sciences’ (KOD) Shift Into Russell Growth Indices Reframing Its Core Investment Story?
Kodiak Sciences Inc. (KOD) has been reclassified from Russell value and microcap indices to Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth. This reclassification primarily affects the investor base rather than altering the company's fundamental
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 05:09
- Source
- Sahm
If You Invested $1,000 in Kodiak Sciences Inc. (KOD)
This article examines the historical performance of Kodiak Sciences Inc. (KOD) stock for investors, detailing what a $1,000 investment would be worth over different periods. It highlights the company's focus as a precommercial, retina-focused biotechnology firm with a pipeline of
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 05:40
- Source
- Stock Titan
[Form 4] Kodiak Sciences Inc. Insider Trading Activity
Kodiak Sciences Inc. director Richard S. Levy was granted 17,731 stock options with an exercise price of $38.96 per share, expiring on June 29, 2036. These options will vest on the earlier of June 30, 2027, or one day before the next annual shareholder meeting, provided Levy rema
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 22:09
- Source
- Stock Titan
Director at Kodiak Sciences (KOD) receives 17,731 stock options award
Kodiak Sciences Inc. director Robert Profusek was granted 17,731 stock options with an exercise price of $38.96 per share, expiring on June 29, 2036. These options will fully vest on the earlier of June 30, 2027, or the day before the company's next annual meeting, provided he re
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 22:09
- Source
- Stock Titan
Form 4 Kodiak Sciences Inc For: 2 July By Investing.com
Investing.com reported on a Form 4 filing for Kodiak Sciences Inc. for July 2nd. The article provides the company name and filing date, alongside various market data and other news headlines, suggesting a brief update on financial regulatory disclosures related to Kodiak Sciences
- Tone
- Positive 59/100
- Event
- Regulatory and legal
- Published
- 02 Jul 2026 21:41
- Source
- Investing.com Canada
17,731 Kodiak Sciences (KOD) options granted tied to Baker funds
Kodiak Sciences director Felix J. Baker was granted 17,731 non-qualified stock options with a strike price of $38.96 per share, which are linked to Baker-affiliated funds. These options, vesting on the earlier of one year post-grant or before the next annual meeting, are issued u
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Kodiak Sciences (KOD) director receives grant of 17,731 stock options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
17,731 options granted to Kodiak (NASDAQ: KOD) board director
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Kodiak Sciences (KOD) director awarded stock options for 17,731 shares at $38.96
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Price to book forward of Kodiak Sciences Inc – NASDAQ:KOD
The article focuses on the "Price to book forward" metric for Kodiak Sciences Inc. under its NASDAQ ticker KOD. It presents financial data for the company within the context of the Health Technology and Biotechnology sectors, as provided by TradingView.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 17:10
- Source
- TradingView
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell Microcap Index
Kodiak Sciences Inc. (NasdaqGM: KOD) has been removed from the Russell Microcap Index, effective June 29, 2026. This news comes alongside several other changes in Russell indices for Kodiak Sciences on the same date, including additions to growth benchmarks and removals from valu
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 30 Jun 2026 06:41
- Source
- www.marketscreener.com
Kodiak Sciences Inc.(NasdaqGM:KOD) added to Russell Small Cap Comp Growth Benchmark
Kodiak Sciences Inc. (NasdaqGM:KOD) has been added to the Russell Small Cap Comp Growth Benchmark, impacting its previous classifications within other Russell indices. The company, a precommercial retina-focused biotechnology firm, is developing three late-stage clinical programs
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 29 Jun 2026 20:05
- Source
- www.marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 3000E Growth Benchmark
Kodiak Sciences Inc. (NasdaqGM: KOD) has been added to the Russell 3000E Growth Benchmark. This news follows several other index-related announcements for the company on the same day, including additions to Russell Small Cap Comp Growth and Russell 2000 Growth benchmarks, and rem
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 29 Jun 2026 08:40
- Source
- www.marketscreener.com
Enterprise value to EBIT forward of Kodiak Sciences Inc – NASDAQ:KOD
This article provides an enterprise value to EBIT forward for Kodiak Sciences Inc (NASDAQ: KOD). It lists the company's stock information, along with various financial and community features available on the TradingView platform. The content primarily focuses on presenting a spec
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 02:09
- Source
- TradingView
Enterprise value to EBITDA forward of Kodiak Sciences Inc – NASDAQ:KOD
This article provides access to the enterprise value to EBITDA forward financial metric for Kodiak Sciences Inc., trading under the NASDAQ symbol KOD. It indicates that the market is currently closed with no trades. The content is primarily a data placeholder within a financial p
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 05:10
- Source
- TradingView
Enterprise value to revenue forward of Kodiak Sciences Inc – NASDAQ:KOD
This article displays the forward enterprise value to revenue for Kodiak Sciences Inc. (NASDAQ: KOD). The data indicates that the market was closed at the time of publication, with no trades reported.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 21:09
- Source
- TradingView
Price to earnings forward of Kodiak Sciences Inc – NASDAQ:KOD
This article provides financial data for Kodiak Sciences Inc (NASDAQ: KOD), specifically its price-to-earnings forward ratio. The content states that the market was closed at the time of publication, and no trades were made. It appears to be a stub or a data point from a financia
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 15:09
- Source
- TradingView
Kodiak Sciences, Inc. Actuals & Estimates (NASDAQ:KOD)
This article provides an overview of Kodiak Sciences Inc. (NASDAQ: KOD) stock, detailing its current price, historical performance, analyst forecasts, and financial data. It highlights the company's market capitalization, upcoming earnings report date, and recent revenue and net
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 26 Jun 2026 07:40
- Source
- TradingView
KOD - Kodiak Sciences Inc Options
This article provides a comprehensive overview of Kodiak Sciences Inc. (KOD) stock performance and financial data. It includes key metrics such as market capitalization, income, sales, P/E ratios, insider and institutional ownership, profitability, and various performance indicat
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 25 Jun 2026 14:39
- Source
- Finviz
KOD - Kodiak Sciences Inc Volatility & Greeks
This article provides a detailed financial snapshot of Kodiak Sciences Inc (KOD), including its market capitalization, income, sales, key financial ratios, stock performance metrics, and analyst recommendations. It highlights the company's significant year-over-year stock perform
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 24 Jun 2026 13:41
- Source
- Finviz
Kodiak Sciences Inc (KOD) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Kodiak Sciences Inc (KOD), based on analysis from 7 analysts. The current target price for KOD is USD 64.000, representing a 79.22% upside, with most analysts recommending a "Buy" trend. The report also details past EPS performance a
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jun 2026 21:09
- Source
- TradingKey
Kodiak Sciences Inc (KOD) Financial Health: Profitability & Balance Sheet Analysis
This article provides an analysis of Kodiak Sciences Inc.'s (KOD) financial health, focusing on profitability and balance sheet metrics. It notes that relevant data for Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns have not yet been disclo
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 09:39
- Source
- TradingKey
Kodiak Sciences Inc (KOD) Institutional Confidence
This article provides details on the institutional confidence in Kodiak Sciences Inc. (KOD), presenting data on institutional shareholdings and recent changes in those holdings. It lists key institutional investors like Baker Bros. Advisors LP and BlackRock, along with their shar
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 17 Jun 2026 21:39
- Source
- TradingKey
Kodiak Sciences Inc (KOD) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Kodiak Sciences Inc (KOD), focusing on key metrics like P/E, P/B, P/S, and P/CF ratios. The analysis indicates that relevant data for these valuation metrics has not yet been disclosed by the company. It serves as a brief overview of
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 21:39
- Source
- TradingKey
Kodiak Sciences: Clinical Redemption Is Turning Into Platform Leverage (NASDAQ:KOD)
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 16 Jun 2026 07:00
- Source
- Seeking Alpha